Health
newsGP – ‘Important’ study shows gout medication can halt coronary disease progression – RACGP
The major clinical trial found use of low dose colchicine reduces heart attacks and the need for coronary stenting or bypass surgery by 30%.
News
The major clinical trial found use of low dose colchicine reduces heart attacks and the need for coronary stenting or bypass surgery by 30%.
Coronary heart disease is the leading cause of death in Australia.
The international study, published in The New England Journal of Medicine, examined the effect of low dose colchicine in patients with chronic coronary disease who were already taking established treatments.The two-year randomised, controlled, double-blind trial, led by GenesisCare i…
-
Noosa News24 hours agoWhat the numbers really say about Crisafulli’s crime crackdown
-
General17 hours agoA feeling of calm before the storm descends on Tasmanian politics following motion of no-confidence in Jeremy Rockliff
-
General24 hours agoThe US dollar’s demise has consequences for Australia
-
Noosa News21 hours agoTwo bodies found in search for missing Brisbane couple in Tasmania